Press release
AI-Based Clinical Trial Solution Providers Market Top Players -Antidote Technologies, Inc. (US), AiCure, LLC (US), Deep 6 AI (US), Deep Lens Inc. (US).
AI-based Clinical Trial Solution Providers Market to Record An Exponential CAGR By 2030.
InsightAce Analytic Pvt. Ltd. reveals the release of a market assessment report on the "Global AI-based Clinical Trial Solution Providers Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get Free Access to Demo Report, Excel Pivot and ToC: www.insightaceanalytic.com/request-sample/1430
According to InsightAce Analytic's most recent research, the global market for AI-based clinical trial solution providers is predicted to grow rapidly over the forecast period. By geography, North America is likely to lead the market.
Clinical trial protocols and research rely heavily on artificial intelligence. AI-powered platforms improve clinical data interpretability and contribute to the resolution of huge and complicated difficulties in clinical research and medical product development. AI platforms enable researchers to examine new compounds and therapeutics in silico.
Advanced digital and medical technologies, rapid innovation of new AI-based platforms/systems, high prevalence of chronic and infectious diseases, increased healthcare expenditure, rising government investments for R&D of clinical trials, increasing use of AI and machine learning techniques, and rising awareness among researchers about AI platforms are expected to boost market growth in the forecast years. Furthermore, biopharmaceutical companies fuel growth in the market for AI-based clinical trial solution providers, since the majority of these organizations choose to speed clinical trials using AI platforms and sophisticated planning and design approaches.
However, rigorous rules governing AI-based clinical trial approvals, as well as a lack of awareness of AI applications or platforms, are projected to limit market growth possibilities over the projection period (2020-2030).
Geographically, North America dominated the AI-based clinical trial solution providers market in 2020 and will continue to do so over the estimated timeframe, followed by Europe, owing to rising human health diseases, rapid adoption of new techniques, and increased clinical R&D funding by the government. The Asia-Pacific region is expected to grow this market in the next years as clinical trials and research investments increase.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Major market players operating in the AI-based clinical trial solution providers market include Antidote Technologies, Inc. (US), AiCure, LLC (US), Deep 6 AI (US), Deep Lens Inc. (US), Innoplexus (Germany), Intelligencia.ai (US), MEDIAN Technologies (France), Mendel.ai (US), Phesi (US), Saama Technologies (US), Unlearn.AI, Inc. (US), and Trials.ai (US), among others.
A few of the developments in the market are as follows:
• In October 2021, Deep Lens (US) collaborated with Southern Oncology Specialists to use the AI-based solution VIPER for improving clinical trial matching. This partnership brings more precision medicine trials to the practice and broadens the practice's existing research program.
• In September 2021, Deep 6 AI (US), the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), introduced Deep 6 for Life Sciences, a novel suite of AI software solutions for life science sponsors and CROs, built on its industry-leading clinical trial acceleration platform. Deep 6 for Life Sciences brings a new level of data-driven precision and insight to sponsors' interventional and observational studies, saving them months and significantly de-risking their research efforts.
• In March 2020, Innoplexus AG (Germany) opened its proprietary Ontosight® AI search platform freely available to all medical researchers worldwide to help fight the COVID-19 pandemic.
Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1430
Market Segments
AI-based Clinical Trial Solution Providers Market, by Target Therapeutic Area, 2020-2030 (Value US$ Mn)
• Cardiovascular Disorders
• CNS Disorders
• Infectious Disorders
• Metabolic Disorders
• Oncological Disorders
• Other Disorders
AI-based Clinical Trial Solution Providers Market, by Trial Phase, 2020-2030 (Value US$ Mn)
• Early Phase 1
• Phase 1
• Phase 2
• Phase 3
• Phase 4
AI-based Clinical Trial Solution Providers Market, by End-Users, 2020-2030 (Value US$ Mn)
• Pharmaceutical Companies
• Academia and Other Users
AI-based Clinical Trial Solution Providers Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Empower Your Decision-Making with 180 Pages Full Report @ www.insightaceanalytic.com/buy-report/1430
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd. reveals the release of a market assessment report on the "Global AI-based Clinical Trial Solution Providers Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get Free Access to Demo Report, Excel Pivot and ToC: www.insightaceanalytic.com/request-sample/1430
According to InsightAce Analytic's most recent research, the global market for AI-based clinical trial solution providers is predicted to grow rapidly over the forecast period. By geography, North America is likely to lead the market.
Clinical trial protocols and research rely heavily on artificial intelligence. AI-powered platforms improve clinical data interpretability and contribute to the resolution of huge and complicated difficulties in clinical research and medical product development. AI platforms enable researchers to examine new compounds and therapeutics in silico.
Advanced digital and medical technologies, rapid innovation of new AI-based platforms/systems, high prevalence of chronic and infectious diseases, increased healthcare expenditure, rising government investments for R&D of clinical trials, increasing use of AI and machine learning techniques, and rising awareness among researchers about AI platforms are expected to boost market growth in the forecast years. Furthermore, biopharmaceutical companies fuel growth in the market for AI-based clinical trial solution providers, since the majority of these organizations choose to speed clinical trials using AI platforms and sophisticated planning and design approaches.
However, rigorous rules governing AI-based clinical trial approvals, as well as a lack of awareness of AI applications or platforms, are projected to limit market growth possibilities over the projection period (2020-2030).
Geographically, North America dominated the AI-based clinical trial solution providers market in 2020 and will continue to do so over the estimated timeframe, followed by Europe, owing to rising human health diseases, rapid adoption of new techniques, and increased clinical R&D funding by the government. The Asia-Pacific region is expected to grow this market in the next years as clinical trials and research investments increase.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Major market players operating in the AI-based clinical trial solution providers market include Antidote Technologies, Inc. (US), AiCure, LLC (US), Deep 6 AI (US), Deep Lens Inc. (US), Innoplexus (Germany), Intelligencia.ai (US), MEDIAN Technologies (France), Mendel.ai (US), Phesi (US), Saama Technologies (US), Unlearn.AI, Inc. (US), and Trials.ai (US), among others.
A few of the developments in the market are as follows:
• In October 2021, Deep Lens (US) collaborated with Southern Oncology Specialists to use the AI-based solution VIPER for improving clinical trial matching. This partnership brings more precision medicine trials to the practice and broadens the practice's existing research program.
• In September 2021, Deep 6 AI (US), the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), introduced Deep 6 for Life Sciences, a novel suite of AI software solutions for life science sponsors and CROs, built on its industry-leading clinical trial acceleration platform. Deep 6 for Life Sciences brings a new level of data-driven precision and insight to sponsors' interventional and observational studies, saving them months and significantly de-risking their research efforts.
• In March 2020, Innoplexus AG (Germany) opened its proprietary Ontosight® AI search platform freely available to all medical researchers worldwide to help fight the COVID-19 pandemic.
Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1430
Market Segments
AI-based Clinical Trial Solution Providers Market, by Target Therapeutic Area, 2020-2030 (Value US$ Mn)
• Cardiovascular Disorders
• CNS Disorders
• Infectious Disorders
• Metabolic Disorders
• Oncological Disorders
• Other Disorders
AI-based Clinical Trial Solution Providers Market, by Trial Phase, 2020-2030 (Value US$ Mn)
• Early Phase 1
• Phase 1
• Phase 2
• Phase 3
• Phase 4
AI-based Clinical Trial Solution Providers Market, by End-Users, 2020-2030 (Value US$ Mn)
• Pharmaceutical Companies
• Academia and Other Users
AI-based Clinical Trial Solution Providers Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Empower Your Decision-Making with 180 Pages Full Report @ www.insightaceanalytic.com/buy-report/1430
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend

/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...

/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...

/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...

/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...

/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...

/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...